Central America vs Denmark: Proportion of the target population who received a 3rd dose of
Central America
80.0%
in 2024
Denmark
96.0%
in 2024
Central America rank
13th
Denmark rank
16th
Proportion of the target population who received a 3rd dose of over time
- Central America
- Denmark
How they compare
Denmark currently reports 96.0% against 80.0% in Central America, a difference of 16.0%.
That makes Denmark's figure about 1.2 times Central America's.
The two have swapped places 2 times across 16 shared years of data; in 2009 it was Denmark ahead.
Central America ranks 13th and Denmark ranks 16th of 37 groups.
Denmark has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Central America | Denmark | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 33.0% | 86.0% | 53.0% | Denmark |
| 2010s | 86.5% | 93.3% | 6.8% | Denmark |
| 2020s | 81.4% | 96.2% | 14.8% | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Central America or Denmark?
- Denmark, at 96.0% against 80.0% in Central America as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Central America and Denmark?
- 16.0%, with Denmark ahead.
- How many years of comparable data are there for Central America and Denmark?
- 16 years are reported by both, from 2009 to 2024.
- How do Central America and Denmark rank globally for proportion of the target population who received a 3rd dose of?
- Central America ranks 13th and Denmark ranks 16th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.